BlackRock
TYRA icon

BlackRock’s Tyra Biosciences TYRA Stock Holding History

BlackRock’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.9M Buy
2,217,929
+131,506
+6% +$4.26M ﹤0.01% 2203
2025
Q4 		$54.9M Buy
2,086,423
+216,949
+12% +$3.98M ﹤0.01% 2459
2025
Q3 		$26.2M Sell
1,869,474
-23,854
-1% -$272K ﹤0.01% 2921
2025
Q2 		$18.1M Buy
1,893,328
+197,411
+12% +$1.88M ﹤0.01% 3091
2025
Q1 		$15.8M Sell
1,695,917
-22,587
-1% -$292K ﹤0.01% 3070
2024
Q4 		$23.9M Buy
1,718,504
+202,332
+13% +$3.67M ﹤0.01% 2927
2024
Q3 		$35.6M Buy
1,516,172
+97,317
+7% +$2.04M ﹤0.01% 2675
2024
Q2 		$22.7M Buy
1,418,855
+374,630
+36% +$6.45M ﹤0.01% 2906
2024
Q1 		$17.1M Buy
1,044,225
+79,191
+8% +$1.3M ﹤0.01% 3073
2023
Q4 		$13.4M Buy
965,034
+68,582
+8% +$888K ﹤0.01% 3244
2023
Q3 		$12.3M Buy
896,452
+5,620
+0.6% +$83.3K ﹤0.01% 3209
2023
Q2 		$15.2M Buy
890,832
+223,947
+34% +$3.25M ﹤0.01% 3199
2023
Q1 		$10.7M Buy
666,885
+11,794
+2% +$140K ﹤0.01% 3280
2022
Q4 		$4.98M Buy
655,091
+32,993
+5% +$233K ﹤0.01% 3728
2022
Q3 		$5.47M Sell
622,098
-8,757
-1% -$80.1K ﹤0.01% 3716
2022
Q2 		$4.51M Buy
630,855
+47,619
+8% +$379K ﹤0.01% 3866
2022
Q1 		$6.24M Sell
583,236
-5,330
-0.9% -$63.3K ﹤0.01% 3835
2021
Q4 		$8.28M Buy
+588,566
New +$11.7M ﹤0.01% 3780

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock's TYRA Position: Q1 2026 in Review

BlackRock increased its Tyra Biosciences (TYRA) stake by 6.3% in Q1 2026, buying an estimated $4.26M and bringing the position to 2,217,929 shares worth $84.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

BlackRock first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • BlackRock held 2,217,929 shares of Tyra Biosciences worth $84.9M as of Q1 2026.
  • BlackRock bought 131,506 Tyra Biosciences shares in Q1 2026, an estimated $4.26M.
  • Tyra Biosciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2203 holding.
  • BlackRock first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.